ARCHIVES

FDA Rile Changes Reporting Requirements for Adverse Events

This article is from The Cancer Letter archive.

Vol. 20 No. 44 | November 18, 1994

Download PDF Visit The Full Archive

Related Articles

NCI Beings Accelerated Review Of R01s That just Miss Payline

March 29, 1996

CCOP Budget Needs Hefty Increase To Fund 55 Awards At Requested Levels, Yates Says

January 30, 1987

J&J, Amgen Settle Lawsuit Over ESAs As FDA Prepares Another Label Change.

July 18, 2008

Samuel Broder Plans To Leave Celera.

September 10, 2010

NCI To Fund About 4,100 Grants; Increase Planned In Average Costs; Paylines Stable

November 20, 1998

Northwestern, Rochester, Howard First In Line For Limited Construction Funds

August 20, 1976